Clinical Trials Logo

Overweight clinical trials

View clinical trials related to Overweight.

Filter by:

NCT ID: NCT03223389 Not yet recruiting - Type 2 Diabetes Clinical Trials

Fat Metabolites and Gut Hormones

Start date: August 7, 2017
Phase: N/A
Study type: Interventional

To investigate the effects of different fat metabolites on gut hormone secretion in gastric bypass operated subjects and BMI-matched controls.

NCT ID: NCT03215173 Completed - Diabetes Clinical Trials

Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease

FAB
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study plans to learn more about how to increase postpartum weight loss and how to decrease risk factors for postpartum women at increased risk for diabetes and heart disease. The program is delivered using a mobile application (app) and a lifestyle coach. This mobile application is developed for women who are at higher risk for diabetes and heart disease. Women who have gestational diabetes, (diabetes during pregnancy, or GDM), gestational hypertension (high blood pressure), and/or preeclampsia (high blood pressure and protein in the urine), and/or small-for gestational-age, and/or preterm (early) delivery during their pregnancies have a higher risk for diabetes and heart disease. This mobile application was developed using the latest research studies and using the evidence-based Diabetes Prevention and Colorado Weigh programs. The goal of the program is to help women lose weight and participate in physical activity after delivery.

NCT ID: NCT03212391 Recruiting - Hypertension Clinical Trials

WAVE Study- Walking and Aging in VErona Study

WAVE
Start date: September 19, 2016
Phase: N/A
Study type: Interventional

Monocentric unblinded two parallel-group randomized controlled trial to evaluate the effect of diet with or without Nordic Walking on weight loss, physical performance and cardiovascular risk factors in overweight and obese population

NCT ID: NCT03208010 Completed - Clinical trials for Overweight and Obesity

Diabetes Prevention for Mexican Americans

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study tests a culturally tailored lifestyle intervention designed to prevent, or delay onset of, T2DM in Mexican Americans with prediabetes. Half the participants take part in a lifestyle program that emphasizes preparing and eating healthy Mexican American foods and increasing physical activity; the other half take part in an "enhanced" usual care control group.

NCT ID: NCT03202043 Completed - Overweight Clinical Trials

The Juice Study: Sensitivity of Skin Carotenoid Status to Detect Change in Intake

Start date: April 6, 2018
Phase: N/A
Study type: Interventional

This study is designed to see if drinking a tomato-based vegetable juice will increase skin carotenoids.

NCT ID: NCT03198793 Completed - Hypertension Clinical Trials

Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins

NEW-HOPE
Start date: October 13, 2017
Phase: Phase 2
Study type: Interventional

Essential hypertension (HTN) is a disease that affects approximately 1 billion individuals worldwide. Despite the availability of effective and safe anti-hypertensive drugs, 65% of subjects diagnosed with HTN do not have their blood pressure (BP) controlled (<140/90 mmHg). The overall incidence of resistant HTN, (defined as requiring 3 or more anti-hypertensive drugs, including a diuretic, to control BP) is estimated to be 15% of the hypertensive population. Consequently, there is a pressing unmet medical need to develop new classes of anti-hypertensive drugs that act on alternative pathways and further control BP and the associated cardiovascular risks in subjects. The prevalence of HTN in African Americans in the United States is among the highest in the world, and HTN is more common in African Americans than in Caucasians. One of the risk factors for HTN is sodium sensitivity. There is a higher association of HTN with sodium sensitivity in African American subjects and other racial/ethnic groups who are overweight/obese. Effective agents to treat HTN in this high-risk population are clearly needed. This study will be conducted in a hypertensive, overweight subject population of multiple ethnic origins in which QGC001 is likely, based on its mode of action, to demonstrate a significant anti-hypertensive effect.

NCT ID: NCT03196453 Not yet recruiting - Overweight Clinical Trials

Fit Child - Clinical Study on Weight Control

FITCHI
Start date: August 1, 2017
Phase: N/A
Study type: Interventional

Children with abnormal weight development of BMI will be given either placebo or a probiotic protein formula and measures of weigh gain during a 3-mont treatment will be conducted

NCT ID: NCT03192254 Completed - Clinical trials for Overweight and Obesity

Understanding Mechanisms of Health Behavior Change

Start date: July 13, 2017
Phase: N/A
Study type: Interventional

This research seeks to examine psychological factors that may impact relationship between incentives and health behavior engagement, specifically fruit and vegetable consumption. Additionally, it will compare the impact of two different incentive schedules on behavior engagement, one providing immediate rewards (i.e. rewards received on a daily basis) and another providing delayed rewards (i.e. rewards received at the end of the study period), with a control condition in which no rewards are offered. Study participants will provide reports of their fruit and vegetable consumption each day for three weeks, and in the two incentive conditions, they will receive small monetary rewards for their fruit and vegetable consumption. Following the three week reporting and reward period, participants will complete two additional assessments, measuring psychological constructs and behavior engagement following the cessation of rewards. The study will also examine how cognitive and anthropomorphic factors may contribute to intervention response and the effects on psychological constructs.

NCT ID: NCT03191591 Completed - Physical Activity Clinical Trials

The First 1,000 Days Program: Maternal-Child Obesity Prevention in Early Life

Start date: August 9, 2016
Phase: N/A
Study type: Interventional

The First 1000 Days (conception to age 2) is a crucial period for the development and prevention of obesity and its adverse consequences in mother-child pairs and their families. The overall aim of the First 1000 Days program is to work across early-life systems to prevent obesity, promote healthy routines and behaviors, address social determinants of health, and reduce health disparities among vulnerable children and families at community health centers in the Boston, MA area. The study aims to simultaneously implement and evaluate an obesity prevention program across early life systems to reduce the prevalence of obesity risk factors within racial/ethnic minority families, close the gap in maternal-child health disparities, and assess and address social determinants of health.

NCT ID: NCT03191331 Completed - Clinical trials for Overweight and Obesity

Dietary Intervention, Gestational Weight Gain and Gestational Diabetes.

Start date: June 6, 2017
Phase: N/A
Study type: Interventional

The aim of this pilot study is to conduct a dietary intervention for overweight (body maas index BMI≥25) and obese (BMI≥30) pregnant women in two maternity care clinics and explore the effect of the intervention on gestational weight gain and the prevalence of gestational diabetes between the intervention and control groups.